Myriad Genetics (MYGN) announced the appointment of Sam Raha as Chief Operating Officer, COO, effective December 11, 2023. In his role as COO, he will be responsible for driving the company’s lab operations, customer service initiatives, and product development innovations. Raha previously served as the President of Agilent’s (A) Diagnostics and Genomics Group where he was responsible for overall strategy along with business and financial results.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on MYGN:
- Myriad Genetics Appoints Sam Raha as Chief Operating Officer
- Myriad Genetics to Release Third Quarter Financial Results on November 6, 2023
- Is MYGN a Buy, Before Earnings?
- Myriad Genetics, Qiagen enter new master collaboration agreement
- Qiagen, Myriad Genetics partner to advance companion diagnostics development